Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine effect on inflammatory markers in post-op patients
NCT01339065Phase 4Unknown
- Sponsor
- Makerere University
- Start
- Apr 2011
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in post-operative inflammation comparing Ketamine with Placebo (2 arms). Primary endpoint: Interleukin-6 at 48 hours. Status: unknown.
02
Drugs
ketamine
03
Conditions
post-operative inflammation
Beyond the preview
Go deeper on NCT01339065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01339065.